---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-049869"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2021-10-04T23:59:59+00:00"
generated_at: "2026-06-28T23:26:49.879844+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Treace Medical Concepts appoints Betsy Hanna and Deepti Jain to Board of Directors

## Summary
- Appointments effective October 1, 2021; Hanna as Class II director (term to 2023), Jain as Class I (term to 2022).
- Hanna to serve on Compensation and NCG Committees; Jain on Audit and NCG Committees.
- Hanna is President/CEO of Clinical Genomics, former J&J Vision Care VP; MBA from Harvard.
- Jain was President of IngenioRX (Anthem), COO of Pharmacy Solutions; MBA from Baruch College.
- Both determined independent under Nasdaq rules; no related-party transactions disclosed.

## SEC filing metadata
- accession: 0001564590-21-049869
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2021-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/tmci-8k_20210930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-049869
- JSON: https://secwatch.observer/filing/0001564590-21-049869.json
- Plain text: https://secwatch.observer/filing/0001564590-21-049869.txt

## Key facts
- Executive change
  Betsy Hanna was appointed as director at TREACE MEDICAL CONCEPTS, INC..
  - Action: appointed
  - Role: director
  source text: appointed Betsy Hanna and Deepti Jain to the Company’s Board effective October 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm
- Executive change
  Deepti Jain was appointed as director at TREACE MEDICAL CONCEPTS, INC..
  - Action: appointed
  - Role: director
  source text: appointed Betsy Hanna and Deepti Jain to the Company’s Board effective October 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.